The present invention relates to a toxin comprising a modified light chain of a botulinum toxin type E, wherein the modified light chain comprises amino acid sequence PFVNKQFN (SEQ ID NO: 120) at the N-terminus, and amino acid sequence xExxxLL (SEQ ID NO: 112) at the C-terminus, wherein x is any amino acid.

 
Web www.patentalert.com

< METHODS AND COMBINATION THERAPIES FOR TREATING ALZHEIMER'S DISEASE

< QUINOLINE DERIVATIVES AS P13 KINASE INHIBITORS

> HETEROMONOCYCLIC COMPOUND AND USE THEREOF

> GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric Disorders
~ 00606